Correlation Between Eli Lilly and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and ProQR Therapeutics BV, you can compare the effects of market volatilities on Eli Lilly and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and ProQR Therapeutics.
Diversification Opportunities for Eli Lilly and ProQR Therapeutics
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eli and ProQR is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Eli Lilly i.e., Eli Lilly and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between Eli Lilly and ProQR Therapeutics
Considering the 90-day investment horizon Eli Lilly and is expected to generate 0.31 times more return on investment than ProQR Therapeutics. However, Eli Lilly and is 3.28 times less risky than ProQR Therapeutics. It trades about 0.48 of its potential returns per unit of risk. ProQR Therapeutics BV is currently generating about -0.04 per unit of risk. If you would invest 80,904 in Eli Lilly and on December 3, 2024 and sell it today you would earn a total of 12,068 from holding Eli Lilly and or generate 14.92% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Eli Lilly and vs. ProQR Therapeutics BV
Performance |
Timeline |
Eli Lilly |
ProQR Therapeutics |
Eli Lilly and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eli Lilly and ProQR Therapeutics
The main advantage of trading using opposite Eli Lilly and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.Eli Lilly vs. Johnson Johnson | Eli Lilly vs. Bristol Myers Squibb | Eli Lilly vs. AbbVie Inc | Eli Lilly vs. Pfizer Inc |
ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Directory Find actively traded commodities issued by global exchanges |